Topic/Keywords | Expert/Area of Expertise | Contact |
Addiction Research neurobiology of drug addiction, cognitive functions, neural control of circulation, brain imaging, positron emission tomography (PET), treatment of drug addiction, addiction to prescription drugs | David P. Friedman, Ph.D.
Professor of Physiology and Pharmacology Holding faculty appointments in both physiology/pharmacology and general surgery, Friedman is a neuroscientist who has worked in the drug abuse field for more than 15 years. He is an expert on how drugs of abuse affect the brain and making new scientific findings accessible to lay audiences. Formerly an official with the National Institute on Drug Abuse, Friedman has focused his research on the effects of cocaine on the brain. Friedman is a co-founder and director of the Addiction Studies Program for Journalists, which has trained more than 125 journalists in the basic science and latest developments in drug addiction research. | Mark Wright mwright@wfubmc.edu (336) 716-3382 |
Addiction Research drug abuse, nonhuman primate (monkey) models of cocaine abuse, brain imaging, behavioral pharmacology, behavioral neuroscience, neuropharmacology | Michael A. Nader, Ph.D.
Professor of Physiology and Pharmacology Nader has studied the problem of cocaine addiction for over 20 years, with grants from the National Institute on Drug Abuse. The cocaine abuse research by Nader and his colleagues is unique in that the Wake Forest monkeys are the only monkeys in the world that give themselves the drug and live in social groups, allowing researchers to study how the reinforcing actions of cocaine are affecting social behavior and the brain. Nader and colleagues are looking at the effect of long-term cocaine use on dopamine receptors. Nader’s research has shown that cocaine creates changes in the brain, that positron emission tomography (PET) imaging can be used to illustrate the level of dopamine activity in the brain, and that social rank, whether an individual is dominant or subordinate, has a significant influence on susceptibility to cocaine abuse. Nader is trying to identify drugs that could be used in fighting cocaine addiction with the least undesirable side effects. | Mark Wright mwright@wfubmc.edu (336) 716-3382 |
Aging Gerontology, Aging and Rehabilitation | Jeff Williamson, M.D.
Associate Professor of Gerontology, Clinical Director of Sticht Center. Williamson is a Co-Investigator in ALLHAT (Anti-Hypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial) the ALLHAT Principal Investigator for the Mid-Atlantic Region, Co-Principal Investigator of the Southeastern Network in the ACCORD (Action to Control Cardiovascular Risks in Diabetics) trial, and Co-Principal investigator for the coordinating center in the Ginkgo Biloba Evaluation of Memory Study (GEMS). He is a junior investigator in the Wake Forest Claude Pepper Center where he is conducting pilot research on the role of ACE inhibitors in preventing disability. | Karen Richardson krchrdsn@wfubmc.edu (336) 716-4453 |
AIDS/ HIV- Pediatrics Pediatric HIV-1 Infection, Neonatal Infections, Infectious Diseases | Avinash Shetty, M.D.
Assistant Professor of Pediatrics/ Infectious Disease Clinical Interests: General Pediatrics, Pediatrics, Pediatric Infectious Diseases
Teaching Interests: Pediatric HIV-1 Infection, Neonatal Infections, Infectious Diseases in Compromised Hosts
Research Interests: Prevention of Mother-to-Child Transmission of HIV-1 in Resource-Poor Countries | Rae Bush rbush@wfubmc.edu (336) 716-6878 |
Alcohol Altered central nervous system (CNS) and control over ethanol ingestion | Herman H. Samson, III, Ph.D.
Professor Emeritus, Department of Physiology and Pharmacology Samson examines the mechanisms which regulate alcohol consumption in rodent models, and has led to a greater understanding of altered CNS activity resulting from alcohol consumption. Samson is currently examining the combined effects of genetic selection, using the alcohol preferring and alcohol non-preferring rat lines combined with various ethanol initiation procedures upon drinking patterns measured in the continuous access drinking situation. Then they will attempt to determine the role of various anatomical and neurotransmitter pathways in ethanol reinforcement. | Mark Wright mwright@wfubmce.edu (336) 716-3382 |
Anesthesiology- Pediatric Pediatric Critical Care, Pediatric Anesthesia, Pediatric Pain Management | Joseph R. Tobin, M.D.
Chair of the Department of Anesthesiology Tobin is an expert on malignant hyperthermia syndrome and an enthusiastic activist for effective pain management in children. He is an investigator or co-investigator on a number of research grants, Tobin is also an author or co-author of 27 books and book chapters, 60 journal articles and 68 published abstracts. | Rae Bush rbush@wfubmc.edu (336) 716-6878 |
Cancer- Colorectal New treatments across a broad range of cancers | Perry Shen, M.D.
Assistant Professor of Surgery – General Shen is one of the few surgeons in the country who is using heated chemotherapy to treat abdominal cancers. He is also currently studying the use of a hepatic pump to deliver chemotherapy directly to the liver. For people with inoperable liver tumors, he is testing the use of focused microwaves to burn out the cancer without having to cut it out, a technique called microwave ablation. He is also involved in a number of breast cancer clinical trials and is the principal investigator for a study on predicting the risk that melanoma, the most dangerous skin cancer, will spread to nearby organs. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer- Liver New treatments across a broad range of cancers | Perry Shen, M.D.
Assistant Professor of Surgery – General Shen is one of the few surgeons in the country who is using heated chemotherapy to treat abdominal cancers. He is also currently studying the use of a hepatic pump to deliver chemotherapy directly to the liver. For people with inoperable liver tumors, he is testing the use of focused microwaves to burn out the cancer without having to cut it out, a technique called microwave ablation. He is also involved in a number of breast cancer clinical trials and is the principal investigator for a study on predicting the risk that melanoma, the most dangerous skin cancer, will spread to nearby organs. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer- Ovarian and Cervical gynecologic oncology (general), chemotherapy, radical surgery, diagnosis and treatment of condyloma and lower genital tract dysplasia | Brigitte Miller, M.D.
Associate Professor of Obstetrics and Gynecology Miller is one of the Southeast’s leading experts in early detection, prevention, diagnosis, surgery and treatment of gynecologic cancers. She is head of our Section of Gynecologic Oncology, assistant editor of The Women's Oncology Review, a recipient of the Excellence in Teaching Award of the Association of Professors of Gynecology and Obstetrics, and the author of more than 200 articles, chapters, presentations and lectures on topics including ovarian cancer, cervical cancer and other gynecological malignancies, gynecological malignancies in HIV disease, and hormones and cancer. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer Research hormones, diet and risk for breast and uterine cancer. | Mark Cline, M.D.
Associate Professor of Comparative Medicine Cline is a board-certified veterinary pathologist – and one of only a few veterinarians to have an NIH-funded research program. Using animal models, he has conducted research on hormones, diet and breast cancer risk since 1994. Important findings include that combined estrogen-progestin treatment increased breast cancer risk and that dietary soy can reduce circulating estrogen concentrations in female monkeys, a possible mechanism for reducing breast and uterine cancer risk. Cline, who was named Distinguished Alumnus of the year in 2001 by the N.C. State University College of Veterinary Medicine, will chair the 2005 meeting of the American College of Veterinary Pathologists in Boston. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-Brain Targeted therapies for brain cancer, brain cancer vaccine research, imaging | Waldemar Debinski, M.D., Ph.D.
Professor of Surgery – Neurosurgery Debinski, the director of the Brain Tumor Center of Excellence at Wake Forest Baptist, is a physician-scientist who pioneered a method to destroy malignant brain tumor cells without harming healthy cells. A drug developed by Debinski was an “unanticipated success” in early clinical trials and is now going through final testing in a phase-3 study. He is also researching brain tumor vaccines and new imaging techniques. He holds eight patents and has published more than 200 scientific reports. He won the Society of Neuro-Oncology’s annual award for Excellence in Basic Research. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-Brain Brain tumors, cancer pain, chemotherapy, experimental therapies | Glenn Lesser, M.D.
Associate Professor of Anesthesiology, Associate Professor of Internal Medicine – Hematology and Oncology Lesser, a medical oncologist, is listed in Best Doctors in America. He directs clinical trials through the Medical Center’s inclusion in a consortium of centers that test novel treatments for brain tumors. He was involved in inventing a device implanted under the skin to release a continuous dose of pain medication. Lesser edited a section on “Central Nervous System Malignancies,” in Current Treatment Options in Oncology. He is a merit award recipient from the American Society of Clinical Oncology. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-Breast All cancers, and is a nationally recognized expert in breast cancer, skin cancer, and cancer of the gastro-intestinal system | Edward Levine, M.D.
Professor of Surgery – General Levine is a general surgeon and principal investigator of a clinical trial of a cancer vaccine for melanoma, the most deadly type of skin cancer. He is principal investigator of the STAR trial, which is looking at the long-term effects of Tamoxifen or Raloxifene and age related changes in thinking and memory. He is also involved in the evaluation of a miniaturized PET scanner for breast imaging to determine if it works better than mammography on breasts that are difficult to penetrate. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-General All cancers, and is a nationally recognized expert in breast cancer, skin cancer, and cancer of the gastro-intestinal system | Edward Levine, M.D.
Professor of Surgery – General Levine is a general surgeon and principal investigator of a clinical trial of a cancer vaccine for melanoma, the most deadly type of skin cancer. He is principal investigator of the STAR trial, which is looking at the long-term effects of Tamoxifen or Raloxifene and age related changes in thinking and memory. He is also involved in the evaluation of a miniaturized PET scanner for breast imaging to determine if it works better than mammography on breasts that are difficult to penetrate. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-General New treatments across a broad range of cancers | Perry Shen, M.D.
Assistant Professor of Surgery – General Shen is one of the few surgeons in the country who is using heated chemotherapy to treat abdominal cancers. He is also currently studying the use of a hepatic pump to deliver chemotherapy directly to the liver. For people with inoperable liver tumors, he is testing the use of focused microwaves to burn out the cancer without having to cut it out, a technique called microwave ablation. He is also involved in a number of breast cancer clinical trials and is the principal investigator for a study on predicting the risk that melanoma, the most dangerous skin cancer, will spread to nearby organs. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-Lung Radiation treatments | William Blackstock, M.D.
Associate Professor of Radiation Oncology
Blackstock, a radiation oncologist, is also a clinical trial investigator in lung, pancreatic, esophageal and rectal cancers. He serves as principal investigator of multiple national and international clinical trials in these cancers. He has considerable experience as a translational clinical scientist, and continues to maintain an active laboratory with National Cancer Institute (NCI) funding. He serves on the executive committee for Cancer and Leukemia Group B (CALGB), a national clinical research group sponsored by NCI. He reviews grants for the NCI Clinical Oncology study section, American Society of Clinical Oncology and the Michael Smith Foundation for Health Research. He also serves on the editorial board for the American Journal of Clinical Oncology. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cancer-Pain Control brain tumors, cancer pain, chemotherapy, experimental therapies | Glenn Lesser, M.D.
Associate Professor of Anesthesiology, Associate Professor of Internal Medicine – Hematology and Oncology Lesser, a medical oncologist, is listed in Best Doctors in America. He directs clinical trials through the Medical Center’s inclusion in a consortium of centers that test novel treatments for brain tumors. He was involved in inventing a device implanted under the skin to release a continuous dose of pain medication. Lesser edited a section on “Central Nervous System Malignancies,” in Current Treatment Options in Oncology. He is a merit award recipient from the American Society of Clinical Oncology. | Jonnie Rohrer jrohrer@wfubmc.edu (336) 716-6972 |
Cardiovascular-Cholesterol preventive cardiology, lipid disorders, risk factors for cardiovascular disease | John Crouse, M.D.
Professor of Internal Medicine – Endocrinology, Professor of Public Health Sciences – Epidemiology Crouse is an endocrinologist whose research and clinical focus is lipid disorders and heart disease prevention. He is a reviewer for New England Journal of Medicine, JAMA, Circulation, and other professional journals. He serves on the editorial boards of Lipid, Arteriosclerosis, Thrombosis, and Vascular Biology. He is a former president of the American Society of Preventive Cardiology and Southeast Lipid Association and serves of the board of directors for the National Lipid Association. | Jim Steele jsteele@wfubmc.edu (336) 716-3487 |
Cardiovascular-General heart disease, heart failure, echocardiography and noninvasive heart testing | Dalane Kitzman, M.D.
Associate Professor of Internal Medicine – Cardiology A cardiologist whose research focuses on heart failure, especially in the elderly, Kitzman’s work has been funded by the National Institute on Aging (NIA) and the American Heart Association. He was among the first to identify diastolic heart failure as a distinct type of disease. Another research focus is improving echocardiography as a diagnostic tool. Kitzman has served on the editorial board of the Journal of the American Geriatrics Society, chaired an NIA study section of clinical aging, and is a past president of the Society for Geriatric Cardiology. | Jim Steele jsteele@wfubmc.edu (336) 716-3487 |
Cardiovascular-Heart Disease noninvasive imaging: echocardiography and MRI; heart structure and function | Greg Hundley, M.D.
Associate Professor of Diagnostic Radiology, Associate Professor of Internal Medicine – Cardiology Hundley, a cardiologist, was the first in the world to use magnetic resonance imaging to visualize and measure blood flow in the coronary arteries, as well as the first to show that MRI stress testing can identify those at risk of heart attack or dying from a heart attack. He trains and teaches physicians worldwide in MRI. He was awarded the National Institute of Health’s “Clinical Associate Physician Award” in 1999 and has published dozens of peer-reviewed articles. | Jim Steele jsteele@wfubmc.edu (336) 716-3487 |
Cardiovascular-Heart Disease Prevention treatment of hypertension and lipid disorders, clinical trials, drug safety | Curt Furberg, M.D., Ph.D.
Professor of Public Health Sciences Furberg is a public health scientist and a national leader in design of clinical trials for heart disease. Currently serves as national chair of several cardiovascular health studies. He is a current member of the Drug Safety and Risk Management Subcommittee of the Pharmaceutical Science Advisory Committee, FDA. Received the 1983 Directors' Award - National Institutes of Health. Co-discoverer of the hazards of calcium channel blockers. | Jim Steele jsteele@wfubmc.edu (336) 716-3487 |
Cardiovascular-Heart Disease Prevention preventive cardiology, lipid disorders, risk factors for cardiovascular disease | John Crouse, M.D.
Professor of Internal Medicine – Endocrinology, Professor of Public Health Sciences – Epidemiology Crouse is an endocrinologist whose research and clinical focus is lipid disorders and heart disease prevention. He is a reviewer for New England Journal of Medicine, JAMA, Circulation, and other professional journals. He serves on the editorial boards of Lipid, Arteriosclerosis, Thrombosis, and Vascular Biology. He is a former president of the American Society of Preventive Cardiology and Southeast Lipid Association and serves of the board of directors for the National Lipid Association. | Jim Steele jsteele@wfubmc.edu (336) 716-3487 |
Cardiovascular-Heart Disease Prevention diet and heart disease, soy, women’s health | Tom Clarkson, D.V.M.
Professor of Comparative Medicine Clarkson is one of the nation's foremost investigators in the effects of nutrition on cardiovascular disease. Internationally known for use of animal models to better understand human atherosclerosis. Research involves coronary heart disease in females, alternative postmenopausal hormone replacement therapies, cardiovascular effects of dietary soy, nutrition and heart disease - causation and prevention, animal studies on hormones and the breast. Past chairman of the Council on Arteriosclerosis of the American Heart Association. Past president of the American College of Laboratory Animal Medicine. | Jim Steele jsteele@wfubmc.edu (336) 716-3487 |
Dermatology-General dermatology, atopic eczema, acne, skin cancer, surgical dermatology, skin disease of aging, itching, cutaneous T-cell lymphoma, geriatric dermatology, phototherapy, nail disease, skin care, effects of tanning | Alan Fleischer, M.D.
Professor of Dermatology Fleischer is chair of dermatology, listed in Best Doctors in America, a reviewer for three major dermatology journals, on the Editorial Board of Archives of Dermatology, and a recipient of the American Academy of Dermatology Continuing Medical Education Award. He has published five dermatology textbooks, and more than 160 peer-reviewed articles. | Ann Hopkins ahopkins@wfubmc.edu (336) 716-1280 |
Dermatology-General general dermatology, effects of tanning, psoriasis, skin cancer, dermatopathology, nail disease, skin care, biochemistry of skin, photoaging; health services research | Steven R. Feldman, M.D., Ph.D.
Professor of Dermatology, Professor of Pathology, Professor of Public Health Sciences - Social Science and Health Policy Triple appointed in Dermatology, Pathology, and Public Health Sciences, Feldman directs the Center for Dermatology Research, a health services research center whose mission is to improve the care of patients with skin disease. His chief clinical interest is psoriasis. He is a member of the Medical Board of the National Psoriasis Foundation, chairs that Board’s Subcommittee on Education, and serves as the director of the Foundation’s Chief Residents’ Meeting on psoriasis treatment. He also chairs the American Academy of Dermatology’s Psoriasis Education Initiative Workgroup, developing regional courses on emerging psoriasis therapies, of which he directs two in 2004. Dr. Feldman is a frequent speaker to lay groups, physicians, industry professionals, and managed care executives, and has published over 200 articles in books and peer-reviewed journals. He is editor or a member of the editorial board of five dermatology journals. | Ann Hopkins ahopkins@wfubmc.edu (336) 716-1280 |
Dermatology-Hair Disorders and Cosmetic general dermatology, hair and scalp disease, ethnic and pigmented skin disease, epidemiology of skin disease | Amy McMichael, M.D.
Associate Professor of Dermatology McMichael has published numerous articles and book chapters in the area of scalp and hair disorders, as well as quality of life issues surrounding disorders of pigmentation. She is currently listed in Best Doctors in America and serves as a diplomat of the American Board of Dermatology. She has also served on several editorial review boards and presently is a contributing editor for Cosmetic Dermatology as well as the continuing medical education editor for Skin and Aging. | Ann Hopkins ahopkins@wfubmc.edu (336) 716-1280 |
Dermatology-Tanning effects of tanning, dermatology, skin cancer, surgical dermatology, skin disease of aging, cutaneous T-cell lymphoma, geriatric dermatology, phototherapy, skin care | Alan Fleischer, M.D.
Professor of Dermatology Fleischer is chair of dermatology, listed in Best Doctors in America, a reviewer for three major dermatology journals, on the Editorial Board of Archives of Dermatology, and a recipient of the American Academy of Dermatology Continuing Medical Education Award. He has published five dermatology textbooks, and more than 160 peer-reviewed articles. | Ann Hopkins ahopkins@wfubmc.edu (336) 716-1280 |
Dermatology-Tanning effects of tanning, general dermatology, skin cancer, dermatopathology, skin care, biochemistry of skin, photoaging; health services research | Steven R. Feldman, M.D., Ph.D.
Professor of Dermatology, Professor of Pathology, Professor of Public Health Sciences - Social Science and Health Policy Triple appointed in Dermatology, Pathology, and Public Health Sciences, Feldman directs the Center for Dermatology Research, a health services research center whose mission is to improve the care of patients with skin disease. His chief clinical interest is psoriasis. He is a member of the Medical Board of the National Psoriasis Foundation, chairs that Board’s Subcommittee on Education, and serves as the director of the Foundation’s Chief Residents’ Meeting on psoriasis treatment. He also chairs the American Academy of Dermatology’s Psoriasis Education Initiative Workgroup, developing regional courses on emerging psoriasis therapies, of which he directs two in 2004. Dr. Feldman is a frequent speaker to lay groups, physicians, industry professionals, and managed care executives, and has published over 200 articles in books and peer-reviewed journals. He is editor or a member of the editorial board of five dermatology journals. | Ann Hopkins ahopkins@wfubmc.edu (336) 716-1280 |
Diabetes diabetes and cardiovascular disease | John Crouse, M.D.
Professor of Internal Medicine – Endocrinology, Professor of Public Health Sciences – Epidemiology Crouse is an endocrinologist whose research and clinical focus is lipid disorders and heart disease prevention. He is a reviewer for New England Journal of Medicine, JAMA, Circulation, and other professional journals. He serves on the editorial boards of Lipid, Arteriosclerosis, Thrombosis, and Vascular Biology. He is a former president of the American Society of Preventive Cardiology and Southeast Lipid Association and serves of the board of directors for the National Lipid Association. | Shannon Koontz skoontz@wfubmc.edu (336) 716-2415 |
Diabetes diabetic eye disease | Craig Greven, M.D.
Professor of Surgery – Ophthalmology Chair of ophthalmology, listed in Best Doctors in America, a reviewer for three major ophthalmology journals, and a fellow of the American College of Surgeons. Recipient of the Honor Award of the American Academy of Ophtha1mology. | Shannon Koontz skoontz@wfubmc.edu (336) 716-2415 |
Economics-Health Policy FDA | Curt Furberg, M.D., Ph.D.
Professor of Public Health Sciences Furberg is a public health scientist and a national leader in design of clinical trials for heart disease. Currently serves as national chair of several cardiovascular health studies. He is a current member of the Drug Safety and Risk Management Subcommittee of the Pharmaceutical Science Advisory Committee, FDA. Received the 1983 Directors' Award - National Institutes of Health. Co-discoverer of the hazards of calcium channel blockers. | Shannon Koontz skoontz@wfubmc.edu (336) 716-2415 |
Economics-Malpractice malpractice crisis | Howard Blumstein, M.D.
Assistant Professor of Surgery - Emergency Medicine Blumstein is the Medical Director of the Emergency Dept. at a university-based level-one trauma center. He also serves on the Board of Directors of the American Academy of Emergency Medicine. Blumstein holds current memberships in the Society of Academic Emergency Medicine, American Academy of Emergency Medicine, Committee of Residency Directors - Emergency Medicine and American Medical Association. | Shannon Koontz skoontz@wfubmc.edu (336) 716-2415 |
Emergency Medicine- Trauma Emergency Trauma, Cardiac Arrest Resuscitation, Emergency Management Services, SWAT (tactical physician), and Disaster Management. | William P. Bozeman, M.D
Associate Professor of Emergency Medicine He is one of a few ER doctors nationwide who is specially trained in trauma and critical care by the Shock Trauma Cen ter in Baltimore, MD. | Bonnie Davis bdavis@wfubmc.edu (336) 716-4977 |
|